The Serotonergic Transmitter System in Dementia and Affective Disorders
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Rigshospitalet, Denmark.
Recruitment status was Recruiting
Information provided by:
First received: September 13, 2005
Last updated: September 26, 2007
Last verified: September 2005
The aim of this project is to examine the serotonergic transmitter system using functional imaging of the brain (positron emission tomography [PET]) to gain knowledge about early pathophysiological changes in Alzheimer's dementia and mood disorders.
||Observational Model: Defined Population
Time Perspective: Cross-Sectional
| Estimated Enrollment:
| Study Start Date:
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- Moderate to severe Alzheimer's disease
- Individuals genetically predisposed to affective disorder
- Healthy gender and age matched controls
- Contraindications to magnetic resonance imaging (MRI)
- Use of psychoactive drugs
- Past or present affective disorder
- Other systemic diseases that may affect brain function
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00192998
|Neurobiological Research Unit
|Copenhagen, Denmark, 2100 |
|Contact: Vibe G. Frokjaer, MD +45 3545 6714 firstname.lastname@example.org |
|Principal Investigator: Vibe G. Frokjaer, MD |
||Vibe G. Frokjaer, MD
||Neurobiological Research Unit, Copenhagen University Hospital, Denmark
No publications provided
History of Changes
|Other Study ID Numbers:
|Study First Received:
||September 13, 2005
||September 26, 2007
||Denmark: Ethics Committee
Keywords provided by Rigshospitalet, Denmark:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on July 26, 2014
Central Nervous System Diseases
Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders